Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rucman

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Journal of Physiology, Paris|October 12, 2001
Lung lesions and anti-ulcer agents beneficial effect: anti-ulcer agents pentadecapeptide BPC 157, ranitidine, omeprazole and atropine ameliorate lung lesion in ratsD Stancic-Rokotov, Z Slobodnjak, J Aralica, et al.
Journal of Physiology, Paris|February 15, 2000
Pentadecapeptide BPC 157 attenuates gastric lesions induced by alloxan in rats and miceM Petek, P Sikiric, T Anic, et al.
Digestive Diseases and Sciences|August 1, 1996
Beneficial effect of a novel pentadecapeptide BPC 157 on gastric lesions induced by restraint stress, ethanol, indomethacin, and capsaicin neurotoxicityP Sikirić, S Seiwerth, Z Grabarević, et al.
Digestive Diseases and Sciences|March 1, 1997
Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stressP Sikirić, B Mazul, S Seiwerth, et al.
Burns : Journal of the International Society for Burn Injuries|November 24, 2001
Pentadecapeptide BPC 157 cream improves burn-wound healing and attenuates burn-gastric lesions in miceD Mikus, P Sikiric, S Seiwerth, et al.
Journal of Physiology, Paris|February 15, 2000
A behavioural study of the effect of pentadecapeptide BPC 157 in Parkinson's disease models in mice and gastric lesions induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydrophyridineP Sikiric, A Marovic, W Matoz, et al.
Journal of Physiology, Paris|October 12, 2001
Portal hypertension and liver lesions in chronically alcohol drinking rats prevented and reversed by stable gastric pentadecapeptide BPC 157 (PL-10, PLD-116), and propranolol, but not ranitidineI Prkacin, J Separovic, G Aralicia, et al.
Journal of Physiology, Paris|May 1, 1997
Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agent-induced gastrointestinal lesions and adjuvant arthritis in ratsP Sikiric, S Seiwerth, Z Grabarevic, et al.
Digestive Diseases and Sciences|May 1, 1997
Pentadecapeptide BPC 157, cimetidine, ranitidine, bromocriptine, and atropine effect in cysteamine lesions in totally gastrectromized rats: a model for cytoprotective studiesP Sikirić, D Mikus, S Seiwerth, et al.
Journal of Physiology, Paris|May 3, 2000
Gastric mucosal lesions induced by complete dopamine system failure in rats. The effects of dopamine agents, ranitidine, atropine, omeprazole and pentadecapeptide BPC 157P Sikiric, J Separovic, G Buljat, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Journal of Physiology, Paris|October 12, 2001
Lung lesions and anti-ulcer agents beneficial effect: anti-ulcer agents pentadecapeptide BPC 157, ranitidine, omeprazole and atropine ameliorate lung lesion in ratsD Stancic-Rokotov, Z Slobodnjak, J Aralica, et al.
Journal of Physiology, Paris|February 15, 2000
Pentadecapeptide BPC 157 attenuates gastric lesions induced by alloxan in rats and miceM Petek, P Sikiric, T Anic, et al.
Digestive Diseases and Sciences|August 1, 1996
Beneficial effect of a novel pentadecapeptide BPC 157 on gastric lesions induced by restraint stress, ethanol, indomethacin, and capsaicin neurotoxicityP Sikirić, S Seiwerth, Z Grabarević, et al.
Digestive Diseases and Sciences|March 1, 1997
Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stressP Sikirić, B Mazul, S Seiwerth, et al.
Burns : Journal of the International Society for Burn Injuries|November 24, 2001
Pentadecapeptide BPC 157 cream improves burn-wound healing and attenuates burn-gastric lesions in miceD Mikus, P Sikiric, S Seiwerth, et al.
Journal of Physiology, Paris|February 15, 2000
A behavioural study of the effect of pentadecapeptide BPC 157 in Parkinson's disease models in mice and gastric lesions induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydrophyridineP Sikiric, A Marovic, W Matoz, et al.
Journal of Physiology, Paris|October 12, 2001
Portal hypertension and liver lesions in chronically alcohol drinking rats prevented and reversed by stable gastric pentadecapeptide BPC 157 (PL-10, PLD-116), and propranolol, but not ranitidineI Prkacin, J Separovic, G Aralicia, et al.
Journal of Physiology, Paris|May 1, 1997
Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agent-induced gastrointestinal lesions and adjuvant arthritis in ratsP Sikiric, S Seiwerth, Z Grabarevic, et al.
Digestive Diseases and Sciences|May 1, 1997
Pentadecapeptide BPC 157, cimetidine, ranitidine, bromocriptine, and atropine effect in cysteamine lesions in totally gastrectromized rats: a model for cytoprotective studiesP Sikirić, D Mikus, S Seiwerth, et al.
Journal of Physiology, Paris|May 3, 2000
Gastric mucosal lesions induced by complete dopamine system failure in rats. The effects of dopamine agents, ranitidine, atropine, omeprazole and pentadecapeptide BPC 157P Sikiric, J Separovic, G Buljat, et al.
Pageof 4